Review
Accepted on 21 May 2025
Astrocyte-Microglia Crosstalk in Subarachnoid Hemorrhage: Mechanisms and Treatments
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1547858
Type at least 3 characters
1,189 articles
General Commentary
Published on 20 May 2025
Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1604337
- 514 views
Original Research
Accepted on 19 May 2025
Human saliva exerts strong type-dependent effects on adenovirus infectivity
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1579896
Original Research
Accepted on 15 May 2025
Cytokine concentration in peripheral blood of patients with childhood obesity
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1606375
Review
Accepted on 13 May 2025
Role of interleukin-16 (IL-16) in human diseases: a novel potential therapeutic target
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1524026
Original Research
Accepted on 12 May 2025
Association Between Pan-Immune-Inflammation Value and Serum Klotho Levels: A Cross-Sectional Analysis of Renal Function Mediation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1567367
- 121 views
Original Research
Accepted on 12 May 2025
IL-17A drives a fibroblast-neutrophil-NET axis to exacerbate immunopathology in the lung with diffuse alveolar damage
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1574246
- 114 views
Review
Accepted on 12 May 2025
Soluble SARS-CoV-2 Spike glycoprotein: considering some potential pathogenic effects
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1616106
- 208 views
Original Research
Published on 08 May 2025
Evaluation of humoral and cellular immune responses in healthcare workers with varying levels of SARS-CoV-2 exposure: effects of CoronaVac vaccination followed by heterologous booster
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1576430
- 767 views
Original Research
Accepted on 07 May 2025
Autophagy crosstalk with the immune microenvironment in chronic myeloid leukemia and serves as a biomarker for diagnosis and progression
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1570903
Original Research
Published on 06 May 2025
Characterization and correlation analysis of oral NET markers and inflammatory factor levels in patients after orthodontic treatment: a pilot study
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1490637
- 381 views
Original Research
Accepted on 02 May 2025
Markers of T cell activation and exhaustion in plasma are associated with persistent symptoms up to 18 months Following Mild SARS-CoV-2 infection
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1578208
Original Research
Published on 02 May 2025
Apolipoprotein M expression modifies the sphingolipid landscape in murine blood and lymph
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1572959
- 1,113 views
Editorial
Published on 01 May 2025
Editorial: The immunological events of macrophages in the course of sepsis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1610868
- 482 views
Review
Published on 01 May 2025
The effects of interleukin-21 in the biology of transplant rejection
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571828
- 780 views
Original Research
Accepted on 28 Apr 2025
High-fat diet-induced adipose tissue-resident macrophages, T cells, and dendritic cells modulate chronic inflammation and adipogenesis during obesity
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1524544
- 196 views